Joseph L Farmer's Net Worth
$2.13 Million
Who is Joseph L Farmer?
Joseph L Farmer has an estimated net worth of $2.13 Million. This is based on reported shares across multiple companies, which include AMAG PHARMACEUTICALS INC., and TESARO, Inc..
SEC CIK
Joseph L Farmer's CIK is 0001317757
Past Insider Trading and Trends
2012 was Joseph L Farmer's most active year for acquiring shares with 7 total transactions. Joseph L Farmer's most active month to acquire stocks was the month of February. 2019 was Joseph L Farmer's most active year for disposing of shares, totalling 9 transactions. Joseph L Farmer's most active month to dispose stocks was the month of December. 2007 saw Joseph L Farmer paying a total of $92,760.00 for 30,500 shares, this is the most they've acquired in one year. In 2019 Joseph L Farmer cashed out on 194,732 shares for a total of $702,525.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMAG PHARMACEUTICALS INC. No price found
SVP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$15.82 | -$13,178.06 |
0
|
Scheduled
|
Feb 24
| ||
Form 4/A
|
—
|
0
|
$17.09 | -$136,739.20 |
0
|
Scheduled
|
Jan 9
| ||
Form 4
|
—
|
0
|
$19.09 | -$152,739.20 |
0
|
Scheduled
|
Jan 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
$15.71 | -$39,275.00 |
0
|
Scheduled
|
Aug 5
| ||
Form 4
|
—
|
0
|
$17.10 | -$14,244.30 |
0
|
Scheduled
|
Feb 24
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 4
|
—
|
0
|
$65.00 | -$97,500.00 |
0
|
Scheduled
|
May 24
| ||
Form 4
|
—
|
0
|
$31.34 | -$566,584.78 |
0
|
Scheduled
|
Mar 8 - Mar 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TESARO, Inc. No price found
Sr VP, Gen Counsel & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.37K |
$75.00 | -$702,525.00 |
0
|
Jan 22
| |||
Form 4
| +5.58% | 438 |
$34.37 | -$6,427.19 | 8.29K |
Scheduled
|
Aug 1
| ||
Form 4
| +69.63% | 3.22K |
$54.86 | -$144,501.24 | 7.85K |
Scheduled
|
Mar 1 - Mar 2
| ||
Form 4
| +15.66% | 625 |
—
|
—
| 4.62K |
Aug 1
| |||
Form 4
| +327.66% | 2.93K |
$177.61 | -$257,356.89 | 3.82K |
Scheduled
|
Mar 1 - Mar 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zenas BioPharma, Inc. (ZBIO) No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||